By Graham Hancock
Here, we asked Graham Hancock about plant medicine, the purpose and meaning of hallucinogenic experiences, and what bigger opportunities he sees for humanity in all of this.
Read on goop.com
CLEAR ALL
Mark Haden is the executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS) Canada as well as an adjunct professor at the University of British Columbia School of Public and Population Health.
1
Benefit for the Oregon Psilocybin Society and the PSI 2020 campaign, Mark Haden, Executive Director of MAPS Canada, considers the potential benefits of psychedelic therapy for couples.
In this very educational episode, Mark Haden returns to update us on what has been transpiring over the past year in the realms of scientific inquiry of psychedelic medicines. Mark is the Chair of MAPS Canada (Multi-Disciplinary Association of Psychedelic Studies).
Mark is the chair of MAPS Canada, and has been educating people about all aspects of drugs for decades. We talk MAPS research with MDMA and trauma, but also harm reduction strategies, speaking to youth about drugs, and strategies for the future of regulating these substances legally.
We are excited to bring you the executive director of MAPS- As we dive into the world of psychedelics and their uses in the world of medicine.
Mark Haden discusses the creative uses for psychoactive drug use for therapeutic purposes.
An uncut interview with Mark Haden on the subject of the War on Drugs. Mark is a professor at the University of British Columbia. He has been published on the issue of drug policy in the Canadian Journal of Public Health, and the International Journal of Drug Policy.
This TEDx talk explores psychedelics in history, the current research and a possible future model of post prohibition regulation based of the model of public health.
Mark Haden is the chair of MAPS Canada, Multi-Disciplinary Association for Psychedelic studies. He is also a 30 plus year Public Health official and adjunct professor at the University of British Columbia. He is a public health and drug policy expert.